Evidence map›Paper›PMID 40752095›Full record

ArticleThe Journal of surgical research2025

Retrospective Cohort Analysis of Outcomes Among Young Onset Breast Cancer Patients in Kijabe, Kenya.

Marissa M Khalil, Kun Bai, Fei Ye, Christine Mwakio, Helena Musau, Beryl Akinyi, Jana Macleod, Rondi M Kauffmann

Abstract read
In one paragraph

Article in The Journal of surgical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marissa M KhalilVanderbilt University School of Medicine, Nashville, Tennessee. Electronic address: mmkhalil562@gmail.com.
Kun BaiDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee.
Fei YeDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee.
Christine MwakioAIC Kijabe Hospital, Kijabe, Kenya.
Helena MusauAIC Kijabe Hospital, Kijabe, Kenya; Department of Medical Oncology, AIC Kijabe Hospital, Kijabe, Kenya.
Beryl AkinyiDepartment of Surgery, AIC Kijabe Hospital, Kijabe, Kenya.
Jana MacleodDepartment of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee; Department of Surgery, Kenyatta University, Nairobi, Kenya.
Rondi M KauffmannDepartment of Surgery, AIC Kijabe Hospital, Kijabe, Kenya; Division of Surgical Oncology and Endocrine Surgery, Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.

Funding

TISSUE CoreP50CA098131 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PARK, BEN HO, PIETENPOL, JENNIFER A · 2003 to 2024
$48.7M
NCI NIH HHS P50 CA098131
6 · The paper itself

Abstract

introductionBreast cancer remains one of the leading causes of morbidity and mortality worldwide, especially for regions of sub-Saharan Africa where little is known about how age of diagnosis relates to breast cancer outcomes. Our study evaluated differences in characteristics and outcomes between those diagnosed with young onset versus average onset breast cancer at a tertiary referral hospital in rural Kenya.

methodsWe performed a retrospective study evaluating breast cancer patients at Kijabe Hospital, dividing cohorts into young (</ = 45 y at diagnosis) and average onset (>45 y). We analyzed tumor characteristics and social factors. Univariate analysis was performed and Cox regression models were fit to analyze the primary outcome of overall survival and secondary outcome of disease-free survival.

resultsThere was no difference when evaluating tumor type (P = 0.06), grade (P = 0.06), hormone receptor positivity (P = 0.29), or metastatic presence (P = 0.27). Patients with early-onset disease were more likely to present with larger tumor size (P < 0.01) and more likely to present with larger nodal burden (P < 0.01). There was no significant difference in overall or disease-free survival between the two groups (P = 0.35 and P = 0.5, respectively).

conclusionsPatients with young onset breast cancer presented with larger tumors and more nodal disease. This suggests delays in presentation, which may be due to gaps in screening, poor education about breast cancer signs, or familial and cultural barriers. Despite this, overall and disease-free survival were not different, suggesting that once diagnosed, younger patients may be treated more aggressively or respond better to treatment. Additional studies are needed to explore these intricacies.

Indexed as

Breast NeoplasmsAdultAge of OnsetDisease-Free SurvivalFemaleHumansKenyaMiddle AgedRetrospective StudiesYoung AdultBreast cancerDiagnosisGlobal healthSurvival

Identifiers

PMID40752095
PMCPMC13337305

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.